Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).
about
Highlight: BRCA1 and BRCA2 proteins in breast cancerHER2 testing: a review of detection methodologies and their clinical performanceTelomerase and cancer: time to move from a promising target to a clinical reality.Testing for her2 in breast cancer: current pathology challenges faced in Canada.c-erbB-2 is not a major factor in the development of colorectal cancerPhase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancerHER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry.Breast cancer patients should not live without a HER-2/neu tissue result--but how safe can they live with it?The in vitro study of Her-2 targeted gold nanoshell liquid fluorocarbon poly lactic-co-glycolic acid ultrasound microcapsule for ultrasound imaging and breast tumor photothermal therapy.Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy.Quantitation of erbB2 positivity for evaluation of high-risk patients
P2860
Q24307401-FE2EBFB6-C054-4D5D-9970-25EFED2360EEQ28280488-923982E8-91F7-462D-A98F-36BC43C4B3DBQ34464335-AB1ECBE4-24EB-4E7C-AF2F-23C5EC21F7C6Q36416223-ECF8D3C7-69E8-41F9-BC38-1421176910EAQ36644043-43C59660-A871-48C5-9395-AB03CB61D76BQ36673566-E20C8F90-0FE7-4329-8EC0-105AAD31B7C2Q38455547-79D2F2E9-091C-459F-BA20-D6502798E73BQ40634215-454BBC77-1ACA-4FCB-91BB-DDAF40516697Q44211870-7CC0008F-AE60-4037-853E-7A51D14D67E8Q47127531-B6A23514-B189-4A1C-911E-A8865CE08447Q47928703-18AC10A9-F2B4-462E-A09E-9784D8DEE3EFQ48610763-FD61F5DE-3CDE-4176-9E2A-D11C06AD9A80Q52042912-268D1289-91AD-4A15-8DEF-AE750274B834Q58136330-803FD317-A487-486E-A01C-8AE441B81A04
P2860
Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Assessment of the need and app ...... owth factor receptor-2 (HER2).
@ast
Assessment of the need and app ...... owth factor receptor-2 (HER2).
@en
Assessment of the need and app ...... ermal growth factor receptor-2
@nl
type
label
Assessment of the need and app ...... owth factor receptor-2 (HER2).
@ast
Assessment of the need and app ...... owth factor receptor-2 (HER2).
@en
Assessment of the need and app ...... ermal growth factor receptor-2
@nl
prefLabel
Assessment of the need and app ...... owth factor receptor-2 (HER2).
@ast
Assessment of the need and app ...... owth factor receptor-2 (HER2).
@en
Assessment of the need and app ...... ermal growth factor receptor-2
@nl
P1476
Assessment of the need and app ...... owth factor receptor-2 (HER2).
@en
P2093
M J van de Vijver
P356
10.1016/S0959-8049(00)00403-2
P478
37 Suppl 1
P577
2001-01-01T00:00:00Z